| dc.date.accessioned | 2018-06-04T16:38:50Z | |
| dc.date.available | 2018-06-04T16:38:50Z | |
| dc.date.issued | 2018-05-25 | |
| dc.identifier.uri | http://dspace.ncl.res.in:8080/xmlui/handle/20.500.12252/3917 | |
| dc.description | Scientists from National Chemical Laboratory and the International Centre for Genetic Engineering and Biotechnology (ICGEB) have achieved a potential breakthrough in anti-malarial research. Three research groups, each led by NCL’s D Srinivasa Reddy and Dhanasekaran Shanmugam, and Amit Sharma of ICGEB, have identified fungal-metabolite molecules as a potential anti-malarial drug. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Times of India | |
| dc.subject | Anti-Malarial Drug | en_US |
| dc.subject | Advanced Malaria Medication | en_US |
| dc.subject | Cladosporin Molecule | en_US |
| dc.subject | Aspergillus Flavus | en_US |
| dc.title | Scientists find potential leads to develop new anti-malarial drugs | en_US |
| dc.title.alternative | Medication for Malaria | en_US |
| dc.type | Newspaper Article | en_US |
| local.division.division | Organic Chemistry Division | en_US |
| dc.description.university | en_US |